SCHEMBL19000709

SCHEMBL19000709

CC(=O)c1cccc(Cn2ncc(Cl)c(Cl)c2=O)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 13/20 0.69
▸ HTT P42858 12/20 0.69
▸ NPSR1 Q6W5P4 11/20 0.69
▸ LMNA P02545 8/20 0.69
▸ CYP1A2 P05177 3/20 0.69
▸ CYP2C19 P33261 3/20 0.69
▸ CYP3A4 P08684 1/20 0.69
▸ SMN1; SMN2 Q16637 7/20 0.58
▸ RAB9A P51151 10/20 0.56
▸ MAPT P10636 8/20 0.56
▸ RECQL P46063 2/20 0.56
▸ MITF O75030 5/20 0.54
▸ PKM P14618 2/20 0.54
▸ POLB P06746 5/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ BLM P54132 1/20 0.51
▸ GPR35 Q9HC97 1/20 0.51
▸ NPC1 O15118 6/20 0.49
▸ HSP90AA1 P07900 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19011632 0.89 HTT (0.67) ALDH1A1HTTNPSR1LMNACYP1A2
SCHEMBL19011793 0.82 HTT (0.71) ALDH1A1HTTNPSR1LMNACYP1A2
SCHEMBL12218257 0.82 HTT (1.00) ALDH1A1HTTNPSR1LMNACYP1A2
SCHEMBL1691901 0.79 HTT (0.71) ALDH1A1HTTNPSR1LMNACYP1A2
SCHEMBL19011761 0.79 HTT (0.71) ALDH1A1HTTNPSR1LMNACYP1A2
SCHEMBL19000707 0.79 HTT (0.70) ALDH1A1HTTNPSR1LMNACYP1A2
SCHEMBL11730204 0.76 NPBWR1 (0.67) ALDH1A1HTTNPSR1LMNACYP1A2
SCHEMBL19000727 0.76 HTT (0.67) ALDH1A1HTTNPSR1LMNACYP1A2
SCHEMBL19011760 0.76 HTT (0.66) ALDH1A1HTTNPSR1LMNACYP1A2
SCHEMBL17997491 0.74 ALDH1A1 (0.46) ALDH1A1MAPTMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS BAK1, DCLRE1B, BLVRB ALDH1A1 4273/4885HTT 4458/4885NPSR1 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback